These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26467022)
21. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related]
22. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
23. CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p. Lu F; Gao J; Luo Y; Jin WL; Wang H; Li CX; Li X Mol Cell Probes; 2023 Oct; 71():101920. PubMed ID: 37442529 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267 [TBL] [Abstract][Full Text] [Related]
25. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
26. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma. Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma. Hung TM; Ho CM; Liu YC; Lee JL; Liao YR; Wu YM; Ho MC; Chen CH; Lai HS; Lee PH PLoS One; 2014; 9(2):e89446. PubMed ID: 24586785 [TBL] [Abstract][Full Text] [Related]
28. Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells. Hu X; Feng Y; Sun L; Qu L; Sun C Dig Dis Sci; 2017 Mar; 62(3):715-722. PubMed ID: 28050784 [TBL] [Abstract][Full Text] [Related]
29. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
30. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Du X; Fan W; Chen Y Gene; 2018 May; 657():30-38. PubMed ID: 29505836 [TBL] [Abstract][Full Text] [Related]
31. MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway. Li S; Shao J; Lou G; Wu C; Liu Y; Zheng M J Exp Clin Cancer Res; 2021 Feb; 40(1):53. PubMed ID: 33526055 [TBL] [Abstract][Full Text] [Related]
32. miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3. Chu Y; Fan W; Guo W; Zhang Y; Wang L; Guo L; Duan X; Wei J; Xu G Oncol Rep; 2017 Jul; 38(1):343-351. PubMed ID: 28586038 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076 [TBL] [Abstract][Full Text] [Related]
34. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
36. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Zhao L; Zhang Y Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008 [TBL] [Abstract][Full Text] [Related]
37. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma. Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833 [TBL] [Abstract][Full Text] [Related]
39. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M; Li M; Wang T; Linghu E; Wu B Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]